Vector Immunology Core
Vector Immunology Core
批准号:
10674936
负责人:
Guangping Gao
金额:
$33.5万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-09 至 2026-07-31
关键词:
AntibodiesAntigensB-LymphocytesBindingBiological AssayCapsidCell TherapyClinicClinical TrialsClustered Regularly Interspaced Short Palindromic RepeatsCystic FibrosisDataDiseaseDisease modelDoseEngineeringEnzyme-Linked Immunosorbent AssayEvaluationFerretsFlow CytometryGene DeliveryGene Transduction AgentGoalsGrantHumanHumoral ImmunitiesImmuneImmune responseImmune systemImmunityImmunological ModelsImmunologyImmunology procedureInflammatoryMeasuresMediatingModelingMonkeysMusNeutralizing antibody assayOutcomePatientsProgram Research Project GrantsProteinsProtocols documentationReagentRegulatory T-LymphocyteResourcesRespiratory Tract InfectionsRoleSerious Adverse EventSerologyStainsStandardizationSteroidsT cell responseT-LymphocyteTestingTherapeuticTransgenesVirusadeno-associated viral vectoralpha 1-Antitrypsin Deficiencycell mediated immune responseclinically relevantcytokinecytotoxicdisease phenotypeenzyme linked immunospot assaygene productgene therapyimmunogenicmouse modelnovelresponsetherapeutic genetransgene expressionvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CORE A - SUMMARY/ABSTRACT:
The Vector Immunology Core will directly support all four projects of this program project
grant by providing reliable, consistent and standardized immunological assays. It will focus on
creating, validating and performing immunological assays to characterize B-cell and T-cell
immune responses to AAV, in mice and ferrets. It will also assay booth immune responses to
capsid and to transgene product. The core will support all four projects by characterizing B-cell
responses by transduction inhibition based NAB assays and ELISAs for capsid binding
antibodies and anti-transgene antibodies. It will develop and standardize assays for evaluating
ferret B-cell responses. It will additionally characterize T-cell responses by ELISPOT, and
cytokine profiling through both ELISA and flow-based cytokine bead assays. Finally, it will
develop flow cytometry staining protocols for the evaluation of Ferret immune responses, which
are currently not well characterized. Overall the immunology core will provide valuable data,
support and resources to all four projects within this program project grant, which will allow for
better understanding of the role the immune system in gene and cell therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vector Immunology Core
-
批准号:10270090
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2021
-
负责人:Guangping Gao
-
依托单位:
Vector Immunology Core
-
批准号:10463804
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2021
-
负责人:Guangping Gao
-
依托单位:
Core C: Viral vector core
-
批准号:10381476
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2020
-
负责人:Guangping Gao
-
依托单位:
Core C: Viral vector core
-
批准号:10625277
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2020
-
负责人:Guangping Gao
-
依托单位:
Novel gene therapy strategies for Canavan disease
-
批准号:8731279
-
项目类别:
-
资助金额:$46.8万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Minimizing transgene clearance
-
批准号:8311212
-
项目类别:
-
资助金额:$53.9万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
AAV Core
-
批准号:8311218
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Novel gene therapy strategies for Canavan disease
-
批准号:8536397
-
项目类别:
-
资助金额:$45.45万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Novel gene therapy strategies for Canavan disease
-
批准号:8440014
-
项目类别:
-
资助金额:$50.28万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Novel Gene Therapy Strategies for Canavan Disease
-
批准号:10561698
-
项目类别:
-
资助金额:$42.24万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Novel Gene Therapy Strategies for Canavan Disease
-
批准号:10338159
-
项目类别:
-
资助金额:$42.24万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Novel Gene Therapy Strategies for Canavan Disease
-
批准号:9912190
-
项目类别:
-
资助金额:$45.93万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Safety and efficacy of optimized AAV3 vectors in murine and NHP livers
-
批准号:8536287
-
项目类别:
-
资助金额:$28.3万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Novel gene therapy strategies for Canavan disease
-
批准号:9145787
-
项目类别:
-
资助金额:$47.27万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Safety and efficacy of optimized AAV3 vectors in murine and NHP livers
-
批准号:8359305
-
项目类别:
-
资助金额:$14.9万
-
财政年份:2012
-
负责人:Guangping Gao
-
依托单位:
Next Generation of Recombinant AAV Serotype For Gene Therapy
-
批准号:9197791
-
项目类别:
-
资助金额:$14.25万
-
财政年份:2010
-
负责人:Guangping Gao
-
依托单位:
MOLECULAR BIOLOGY OF AAV IN LIVER
-
批准号:8147963
-
项目类别:
-
资助金额:$48.01万
-
财政年份:2010
-
负责人:Guangping Gao
-
依托单位:
Next Generation of Recombinant AAV Serotype For Gene Therapy
-
批准号:9252509
-
项目类别:
-
资助金额:$78.86万
-
财政年份:2010
-
负责人:Guangping Gao
-
依托单位:
Next Generation of Recombinant AAV Serotype For Gene Therapy
-
批准号:9057118
-
项目类别:
-
资助金额:$62.22万
-
财政年份:2010
-
负责人:Guangping Gao
-
依托单位:
Molecular Biology of AAV in Liver
-
批准号:7595330
-
项目类别:
-
资助金额:$42.71万
-
财政年份:2009
-
负责人:Guangping Gao
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: